Clinical Trial Update: Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous Catheters [NA]

View source ↗

Summary

The study evaluating the Initial Specimen Diversion Device for peripheral IV blood collection sponsored by Magnolia Medical Technologies was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septicemia

Drugs mentioned

• Initial Specimen Diversion Device

Snippet

Sponsor: Magnolia Medical Technologies, Inc. | Conditions: Septicemia | NA | Status: TERMINATED